Bio-Rad Laboratories

Update in progress

BIO (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life-science research and clinical diagnostic products worldwide. It has two segments: Life Science and Clinical Diagnostics. Life Science provides instruments, reagents, and consumables to separate, purify, and quantify cells, proteins, and nucleic acids for research, biopharma, quality control, and education. Clinical Diagnostics offers diagnostic systems, kits, controls, and software for clinical and hospital labs. Products are sold directly and through distributors. Founded 1952; headquartered in Hercules, California.

Company score

Sentiment: 0.22; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.03; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.25; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.08; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.10; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.16; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive